Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/184333
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZubiaurre Elorza, Leire-
dc.contributor.authorCerdán, Sebastián-
dc.contributor.authorUribe, Carme-
dc.contributor.authorPérez Laso, Carmen-
dc.contributor.authorMarcos, Alberto-
dc.contributor.authorRodríguez del Cerro, Ma Cruz-
dc.contributor.authorFernandez, Rosa-
dc.contributor.authorPásaro, Eduardo-
dc.contributor.authorGuillamon, Antonio-
dc.date.accessioned2022-03-22T15:57:49Z-
dc.date.available2022-03-22T15:57:49Z-
dc.date.issued2021-12-23-
dc.identifier.issn2689-4653-
dc.identifier.urihttps://hdl.handle.net/2445/184333-
dc.description.abstractTransgender men (TM) experience an incongruence between the female sex assigned when they were born and their self-perceived male identity. Some TM seek for a gender affirming hormone treatment (GAHT) to induce a somatic transition from female to male through continuous administration of testosterone. GAHT seems to be relatively safe. However, testosterone produces structural changes in the brain as detected by quantitative magnetic resonance imaging. Mainly, it induces an increase in cortical volume and thickness and subcortical structural volume probably due to the anabolic effects. Animal models, specifically developed to test the anabolic hypothesis, suggest that testosterone and estradiol, its aromatized metabolite, participate in the control of astrocyte water trafficking, thereby controlling brain volume.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.relation.isformatofReproducció del document https://doi.org/10.1089/andro.2021.0008-
dc.relation.ispartofAndrogens: Clinical Research and Therapeutics, 2021, vol. 2, num. 1, p. 252-260-
dc.relation.urihttps://doi.org/10.1089/andro.2021.0008-
dc.rightscc by (c) Zubiaurre Elorza, Leire et al., 2021-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Medicina)-
dc.subject.classificationAnabolitzants-
dc.subject.classificationTransgèneres-
dc.subject.classificationGlutamina-
dc.subject.classificationTestosterona-
dc.subject.classificationAstròcits-
dc.subject.otherAnabolic steroids-
dc.subject.otherTransgender people-
dc.subject.otherGlutamine-
dc.subject.otherTestosterone-
dc.subject.otherAstrocytes-
dc.titleThe Effects of Testosterone on the Brain of Transgender Men-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.typeinfo:eu-repo/semantics/article-
dc.identifier.idgrec718744-
dc.date.updated2022-03-22T15:57:49Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (Institut de Neurociències (UBNeuro))

Files in This Item:
File Description SizeFormat 
718744.pdf755.33 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons